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Totipotent cells in early embryos are progenitors of
all stem cells and are capable of developing into
a whole organism, including extraembryonic tissues
such as placenta. Pluripotent cells in the inner cell
mass (ICM) are the descendants of totipotent cells
and can differentiate into any cell type of a body ex-
cept extraembryonic tissues. The ability to contribute
to chimeric animals upon reintroduction into host
embryos is the key feature of murine totipotent and
pluripotent cells. Here, we demonstrate that rhesus
monkey embryonic stem cells (ESCs) and isolated
ICMs fail to incorporate into host embryos and
develop into chimeras. However, chimeric offspring
were produced following aggregation of totipotent
cells of the four-cell embryos. These results provide
insights into the species-specific nature of primate
embryos and suggest that a chimera assay using
pluripotent cells may not be feasible.
INTRODUCTION
Embryonic stem cells (ESCs) are the in vitro counterparts of
pluripotent cells residing in the inner cell mass (ICM) of blasto-
cysts (Evans and Kaufman, 1981; Martin, 1981; Thomson
et al., 1995, 1998). Whereas natural pluripotent cells in the devel-
oping embryo exist transiently, ESCs can be maintained in vitro
indefinitely, providing an unlimited source of undifferentiated
cells. When reintroduced into blastocysts, mouse ESCs engraft
into the ICMs and participate, in concert with host embryonic
cells, in the development of chimeric fetuses and offspring
(Bradley et al., 1984). Furthermore, in ICM-deficient, tetraploid
host embryos, injected mouse ESCs can rescue the embryo
proper, resulting in exclusively ESC-derived offspring (Nagy
et al., 1990). This unique feature of ESCs has been greatly
exploited in the creation of knockout mice and studies of mam-
malian gene function (Capecchi, 1989).
The first chimera studies of Tarkowski (1961) and Mintz (1962)
independently demonstrated that two or more cleaving mouse
embryos when aggregated together could produce a single
chimeric mouse of normal size. The organs and tissues of such
animals consist of amixture of genetically divergent cells derivedfrom the parental embryos. Amodified techniquewas developed
by Gardner (1968), whereby cells injected into blastocysts were
incorporated into the host ICM to form chimeras. A variety of
donor cell types support mouse chimera production, including
ICM (Gardner, 1968), teratocarcinoma cells (Mintz and Illmen-
see, 1975), ESCs (Bradley et al., 1984), embryonic germ cells
(Matsui et al., 1992), as well as pluripotent cells experimentally
generated by somatic cell nuclear transfer (SCNT) (Wakayama
et al., 2001) or direct reprogramming (induced pluripotent stem
cells [iPSCs]) (Okita et al., 2007). Chimeric animals have also
been produced in several other mammals including rats (Mayer
and Fritz, 1974), rabbits (Gardner and Munro, 1974), sheep
(Tucker et al., 1974), and cattle (Brem et al., 1984). Moreover,
live chimeras have been produced by aggregating preimplanta-
tion embryos of different species (Fehilly et al., 1984). The ability
of mouse cultured pluripotent cells, including those derived
experimentally, to contribute to chimeric tissues of the embryo
proper after introduction into preimplantation host embryos
has become an ultimate test for pluripotency. However, such a
stringent chimera-based pluripotency assay has not been devel-
oped for primates, in large part, due to the limited availability of
animals and the lack of relevant technological and genotyping
expertise.RESULTS
Potential of Monkey ESCs to Form Chimeras
We initially evaluated the ability of rhesus monkey ESCs to
contribute to chimeric fetuses upon injection into in vitro fertiliza-
tion (IVF)-derived host blastocysts. To aid in the tracking of in-
jected cells, we transduced ESCs with a lentiviral vector carrying
GFP and selected pure populations of cells highly expressing the
transgene. Approximately 20–30 disaggregated ESCs were in-
jected into the host blastocyst and placed next to the ICM (Fig-
ure S1; Movie S1, ESC injection). To eliminate risks that ESC
disaggregation may affect cell survival, some blastocysts were
injected with mechanically dispersed cell clumps. To exclude
the possibility that GFP-expressing ESCs may have compro-
mised developmental potential, we also injected nontransgenic
ESCs. We evaluated several previously characterized rhesus
ESC lines including IVF-derived ORMES-22 (XX) and -23 (XY)
as well as SCNT-derived CRES-2 (Byrne et al., 2007).
A total of 26 ESC-injected blastocysts were immediately trans-
planted into seven synchronized recipients. The details of thisCell 148, 285–295, January 20, 2012 ª2012 Elsevier Inc. 285
Table 1. Summary of In Vivo Chimera Studies with Rhesus Monkey ESCs and Embryos
Tested Cells Host Embryo Stage Total Offspring Generated Developed to Separate Embryo Developed to Embryo Proper Chimera
ORMES-22 blastocyst 4 no no
ORMES-23 blastocyst 2 no no
CRES-2 GFP blastocyst 1 no no
Whole ICM blastocyst 3 yes restricteda (hematopoietic)
Four-cell embryo four-cell embryo 10 no yes
ORMES-22 GFP four-cell embryo 1 no no
ORMES-22 (XX) and -23 (XY) are IVF-derived rhesus monkey ESC lines. CRES-2 (XY) is a SCNT-derived ESC line (Byrne et al., 2007).
See also Tables S1, S2, S3, S4, S5, and S6, Figures S1, S2, S3, S4, S5, and S6, and Movie S1.
a Chimerism was restricted to livers, spleens, and placentas.experiment including host embryo stage, ESC type, and embryo
transfer outcomes are presented in Table S1. Four females
became pregnant—one carrying quadruplets and three carrying
singletons. In addition, three recipients contained gestational
sacs without fetuses. The overall pregnancy and implantation
rates were 57% (4/7) per recipient animal and 27% (7/26) per
embryos transferred, respectively. All pregnancies were termi-
nated at midgestation, and seven fetuses were recovered by
caesarean section. Multiple tissues and organs from each fetus
were analyzed for the presence of ESC progeny by (1) microsa-
tellite parentage analysis of genomic DNA employing 41 short
tandem repeats (STR); (2) mitochondrial (mt)DNA parentage
analysis using restriction fragment length polymorphism (RFLP);
and (3) direct GFP fluorescence analysis followed by GFP-
specific PCR. None of these assays showed a contribution of
ESCs in analyzed fetuses (Table 1).
Potency Determination in Monkey ICMs
The failure to generate chimeras may indicate either limited
developmental potential of primate ESCs or inability of host blas-
tocysts to incorporate foreign embryonic cells. To address these
questions, we tested whether noncultured pluripotent cells re-
siding in the ICM can incorporate into host embryos and form
chimeras. Our attempts to enzymatically disaggregate monkey
ICMs into single cells prior to injections resulted in poor survival
and cell death. Therefore, whole ICMs were immunosurgically
isolated from IVF-produced expanded blastocysts and immedi-
ately injected into host blastocysts from unrelated monkeys
(Figure S1; Movie S1, ICM injection). A total of 44 ICM-injected
blastocysts were generated and transferred into 11 recipients
(Table S1). Three females were confirmed pregnant based on
blood progesterone profiles. However, one recipient carried a
single gestational sac without a viable fetus. The second recip-
ient (recipient #10) carried two sacs; one was empty, whereas
the second contained two fetuses separated by a thin mem-
brane, indicative of a monochorionic di-amniotic twin pregnancy
(Figures 1A and 1B). The third recipient (recipient #18) carried
a single gestational sac with one fetus. The pregnancy and
implantation rates with ICM-injected blastocysts were 18%
(2/11) and 7% (3/44), respectively (Table S1). All three fetuses
were recovered by caesarean section as described above and
analyzed for the contribution of transplanted ICMs.
Naturally occurring, monochorionic twin pregnancies usually
carry monozygotic, genetically identical fetuses due to sponta-286 Cell 148, 285–295, January 20, 2012 ª2012 Elsevier Inc.neous duplication of the embryo during early stages of develop-
ment (Cunningham andWilliams, 2005). Unexpectedly, our initial
morphological examinations of the monochorionic twin preg-
nancy revealed that the fetuses were of different genders
(ICM-f1—female and ICM-f2—male). Moreover, detailed STR
analysis demonstrated that one fetus originated from the host
blastocyst, whereas the second fetus was derived from the in-
jected ICMs (Figure 1 and Table S2). Interestingly, we detected
chimerism in the livers and spleens of both fetuses, but not in
other organs and tissues. For example, analysis of the STR locus
for D11S2002 in livers indicated the presence of three different
alleles representing both the host blastocyst and injected ICM
(Figure 1). In addition, the gender-specific STR marker (AME)
confirmed the presence ofmale cells within the liver of the female
fetus ICM-f1. To further validate these results, we analyzed
gender using PCR-based size differences in the amplicons
of the X- and Y-linked zinc finger protein genes (ZFX and ZFY)
(Mitalipov et al., 2007) and confirmed chimerism in livers and
spleens. We also genotyped fetal mtDNAs based on the G/A
single-nucleotide polymorphism (SNP) within the rhDHV1 region
(Tachibana et al., 2009) and the ability of the SphI (PaeI) enzyme
to digest the G but not the A allele. MtDNA analysis confirmed
that ICM-f2 originated from transplanted ICM and chimerism in
livers and spleens (Figure 1). The placental sample containing
a mixture of several extraembryonic membranes (including cho-
rion and amnion) was contributed by both the host embryo and
injected ICM.
The fetus associated with the singleton pregnancy (ICM-f3)
was male and originated solely from the injected ICM, whereas
theplacental (trophectoderm) componentwas female andmainly
contributed by the host blastocyst (Figure 2 and Table S2).
These results demonstrate that contrary to the mouse and
some other species, monkey blastocysts do not readily incorpo-
rate ESCs or foreign ICMs and form embryo proper chimeras.
However, transplanted ICMs were capable of forming separate
viable fetuses while sharing the trophectodermal compartment
of the host embryo. The chimerism detected exclusively in livers
and spleens of twin fetuses could result from the exchange of
blood and hematopoietic progenitors through placental per-
fusions. We also observed contribution of transplanted ICMs
to extraembryonic membranes. This is an expected outcome
based on the evidence that mouse ICMs contribute to several
vital extraembryonic tissues including amnion and extraembry-
onic mesoderm of the chorion (Nagy et al., 1990).
Production of Monkey Chimeras by Aggregation
of Four-Cell Embryos
We reasoned that the totipotent blastomeres of cleaving
embryos should be capable of incorporating foreign blastomeres
and forming chimeras. We focused on the four-cell stage based
on the evidence that an isolated single blastomere from this
stage embryo can implant and develop into a viable rhesus
offspring (Chan et al., 2000). To investigate this, we initially
attempted to generate chimeric embryos by replacing two blas-
tomeres in the four-cell stage embryo with two blastomeres
isolated from different developmentally comparable embryos
(Figure S1). We generated 29 chimeric four-cell embryos of
which 19 reached the blastocyst stage. Analysis revealed that
only 10 of these blastocysts contained total cell counts similar
to nonmanipulated controls, indicative of successful aggregation
(Table S3). However, remaining embryos either failed to aggre-
gate and formed two separate blastocysts or developed into
a single blastocyst with significantly reduced cell numbers, indi-
cating that either transplanted or host blastomeres arrested and
failed to contribute to chimeric blastocysts (Figure S2). We also
observed blastocysts with two distinct cavities or two ICMs
within a single trophectoderm vesicle (Figure S2). Although we
did not incorporate markers that would distinguish between
donor and host blastomeres, this phenomenon was not seen in
control intact embryos or in prior studies of preimplantation
embryogenesis (Wolf et al., 2004). Nevertheless, these obser-
vations motivated us to carry out further studies whereby we
aggregated together whole embryos in order to increase the
yield of chimeric blastocysts and eventually offspring.
We reasoned that aggregating of three or more whole cleaving
embryos together would allow better contact between blasto-
meres and ensure that at least two of these embryos would
develop to blastocysts and contribute to chimeric ICMs (Fig-
ure S1). We created a total of 29 aggregates using between three
and six individual four-cell stage embryos and cultured to the
blastocyst stage (Table S4). Remarkably, all 29 aggregates
developed to blastocysts, and cell count analysis suggested
that 26 blastocysts (90%) consisted of at least twice the normal
cell counts, indicating successful aggregation (Table S5 and Fig-
ure S3). To corroborate these observations, we injected GFP-
RNA construct into parental oocytes and generated GFP-
expressing cleaving embryos. GFP signal was always confined
to the RNA-injected oocytes and daughter blastomeres but
was not found in aggregated blastomeres from noninjected
embryos (Figure S3). We aggregated GFP-tagged embryos
with noninjected controls and confirmed successful aggregation
of parental embryos into a singe blastocyst. Finally, we selected
14 chimeric blastocysts consisting of high cell counts and trans-
planted these into five recipient females (Table S1). All five recip-
ients became pregnant, including two with singletons, two with
twins, and one female carrying quadruplets. The pregnancy
and implantation rates with chimeric blastocysts were 100%
(5/5) and 71% (10/14), respectively. These remarkably high preg-
nancy outcomes were not seen among other treatments in this
study or in our prior studies (Wolf et al., 2004). On average, preg-
nancy and implantation rates with nonmanipulated rhesus
embryos do not exceed 36% and 17%, respectively (Wolf
et al., 2004). High pregnancy and implantation results observedwith chimeric blastocysts suggest that higher cell numbers in
embryos are critical for pregnancy initiation.
Three pregnancies with chimeric embryos were terminated,
and seven fetuses recovered for genetic analysis. Remarkably,
all fetuses were of normal size and had no obvious defects or
congenital abnormalities. As expected, STR analysis confirmed
that all seven fetuses were indeed chimeras (Table S6). More-
over, chimerism was found in all sampled organs and tissues
of all fetuses. Some chimeras displayed up to five different alleles
within informative individual STR loci, indicating that at least
three separate genotypes (embryos) contributed to chimeric
tissues (Figure S4; Table S6). Further, the AME marker allows
us to determine the gender of fetuses, and three chimeras
(EA-f1, 5, and 7) were identified as sex chimeras, indicating
that contributing parental embryos were of different genders.
Because several chimeras were generated by aggregating
embryos from two unrelated females, we also used mtDNA
genotyping to confirm presence of two different mtDNA haplo-
types in offspring (Figures S4 and S5).
The remaining two recipients (#25 and #27) were allowed to
carry pregnancies to term and delivered healthy twin (named
Roku and Hex) and singleton (Chimero) infants, respectively (Fig-
ure 3). All three infants were phenotypic males with no obvious
congenital abnormalities. We genotyped cord blood, cord (rep-
resenting yolk sac and allantois), fetal membrane (representing
amnion, chorion, and decidua), and placental (chorio-amniotic
placenta) samples and confirmed that all three infants were
indeed chimeras (Figure 3). To our knowledge, these infants
are the world’s first primate chimeras. Although all three off-
spring were phenotypic males, we reasoned that these infants
could also be sex chimeras due to the high probability that
some contributing embryos were genetically females (XX). To
investigate this, we carried out detailed cytogenetic analyses
of blood by G-banding and fluorescence in situ hybridization
(FISH). Indeed, results confirmed that blood samples from
Roku contained both male and female cells. Molecular cytoge-
netic studies revealed the presence of two signals for the rhesus
monkey X chromosome in approximately 4% of analyzed cells,
whereas remaining cells showed one signal for the X chromo-
some and one signal for the Y chromosome (Figure S6).
Lineage Segregation in Primate Blastocysts
We next revisited the question of why monkey blastocysts
are unable to incorporate transplanted ICMs or ESCs and
form embryo proper chimeras. Mouse chimeras with ESCs are
routinely generated using embryonic day (E) 3.5 blastocysts as
host embryos. However, the ability to form chimeras sharply
declines when more advanced stage host blastocysts are used
(Ohta et al., 2008). Although underlying mechanisms remain
unclear, differentiation of host ICMs into epiblast (EPI) and extra-
embryonic progenitors is believed to restrict homing of injected
ESCs into an ICM (Ohta et al., 2008). For example, in peri-implan-
tation mouse blastocysts (E4.5), the ICM differentiates into two
restricted lineages, EPI and the primitive endoderm (PE) (Cha-
zaud et al., 2006; Morrisey et al., 1998). Developmental studies
indicated that although the ICMs of E3.5 mouse blastocysts
can contribute to all tissues except those of trophectodermal
origin, chimeric contributions of EPI or PE cells are restrictedCell 148, 285–295, January 20, 2012 ª2012 Elsevier Inc. 287
Figure 1. Monochorionic Twin Fetuses Produced by Injection of an ICM into a Blastocyst
(A) Ultrasonography image of a twin pregnancy at 30 days of gestation. Asterisks depict individual fetuses.
(B) Morphological analysis of fetuses recovered on day 51 of gestation. Note that whereas two fetuses share a single placenta, a thin septum (arrowheads)
separates each fetal cavity, indicating monochorionic but di-amniotic pregnancy.
(C) PCR amplification of ZFX and ZFY regions produced two DNA fragments (male and female). Detection of 771 bp fragment in liver and spleen samples of
ICM-f1 indicates presence of male cells in female organs.
(D) Analysis of D11S2002 and AME microsatellite loci detected the presence of three different alleles in livers and a placenta of fetuses.
288 Cell 148, 285–295, January 20, 2012 ª2012 Elsevier Inc.
Figure 2. Parentage Analysis of Offspring Derived from the ICM
(A) Gender-specific PCR analysis demonstrating normal profiles for rhesus male (two fragments of 1149 bp and 771 bp size) and female (one 1149 bp fragment)
DNA samples. Analysis of tissues and organs from ICM-f3 fetus produced by ICM injection demonstrated that the fetus is male whereas the placenta is female. In
addition, the placenta showed a faint 771 bp fragment (arrowhead) indicating presence of male cells at low levels.
(B) Microsatellite genotyping within the STR locus 9P06 clearly demonstrating that the fetus originated from the injected ICM, whereas placenta was mainly from
the host blastocyst. AME STR locus showed a limited presence of male cells in the female placenta possibly indicating amniotic contribution from the trans-
planted ICM.
(C) Chromatogram ofmtDNADHV1 region demonstrating informative SNPs that can distinguishmitochondrial contribution in tissues. AmtDNA profile of the ICM-
f3 fetus matched to the transplanted ICM, whereas the placental mitochondrial genome was a mixture of the host blastocyst and ICM-f3. Limited mtDNA
contribution from the fetus was also evident in the placental tissues.
See also Table S2 for detailed STR data.to their own lineages (Gardner, 1982, 1984; Gardner and Ros-
sant, 1979). We reasoned that such differentiation and segrega-
tion may already be initiated in the ICMs of monkey blastocysts,
thus restricting their chimeric potential. To investigate this possi-
bility, we immunolabeled whole monkey blastocysts or isolated
ICMs with markers for EPI (NANOG) and PE (GATA-6). The
results indicated that blastocysts indeed contain a layer of
GATA-6-positive cells overlaying NANOG-positive EPI cells
within ICMs (Figure S7). Even early monkey blastocysts con-(E) Chromatogram of the rhesusmtDNADHV1 region showing informative SNPs. F
the injected ICM.
(F) mtDNA RFLP analysis. G allele in mtDNA of the host blastocyst egg donor fe
injected ICM egg donor female #6 precludes restriction. mtDNA haplotype of egg d
from the ICM egg donor female #6.
Abbreviations in (C): MW, M, F, He, Li, Br, Kid, Sp, Lu, St, Pl, and neg indicate mo
placenta, and negative control, respectively.
See also Table S2 for detailed STR data.tained spatially segregated GATA-6-positive cells within ICMs.
Thus, it is reasonable to speculate that primate ICMs in preim-
plantation blastocysts consist of at least two lineage-restricted
cell types resulting in limited ability to incorporate foreign plurip-
otent cells.
ESC Integration into Four-Cell Embryos
Based on our results suggesting that monkey cleaving four-cell
embryos are capable of incorporating foreign embryonic cellsetus ICM-f1 originated from a host blastocyst, whereas ICM-f2 developed from
male #5 is recognized and digested by SphI (PaeI), whereas an A allele in the
onor female #5 was detected in the liver and spleen of the ICM-f2 fetus derived
lecular weight, male, female, heart, liver, brain, kidney, spleen, lung, stomach,
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Figure 3. Chimeric Infants Generated by Whole-
Embryo Aggregation
(A and B) Live chimeric offspring (Roku, Hex [indicating
‘‘six’’ in Japanese and Greek], and Chimero) each pro-
duced by aggregating of six individual embryos. The
pictures were taken at 7 days after birth.
(C and D) Genetic analysis of blood and extraembryonic
tissues based on microsatellite examination demon-
strating presence of more than two alleles for each locus.
See also Tables S4 and S6 and Figure S6.and forming chimeras, we reasoned that injection of ESCs into
four-cell embryos might support generation of embryo proper
chimeras. GFP-expressing monkey ESCs were injected under
the zona pellucida and placed between blastomeres of four-
cell embryos and resulting aggregates cultured to the blastocyst
stage. We examined blastocysts for aggregation with ESCs
based on GFP expression and transferred six GFP-positive em-
bryos into two recipients (Figure 4 and Table S1). One became
pregnant carrying a singleton fetus that was recovered at midg-
estation for the analysis. However, again, we found no contribu-
tion of ESCs in tested tissues and organs.
Because ESCs are pluripotent and are not developmen-
tally equivalent to host totipotent blastomeres of the four-cell
embryo, we reasoned that injected ESCsmay prematurely differ-
entiate prior to blastocyst formation, thus precluding their contri-
bution to the ICM. To test this assumption, we injected GFP-
expressing ESCs into four-cell embryos and analyzed resulting
blastocysts by immunocytochemistry. Based on GFP expres-
sion, the majority of blastocysts contained embedded ESCs
within TE or ICM (Figure 4). In some blastocysts, ESCs detached
from host embryos and formed free-floating embryoid bodies.
We selected and labeled blastocysts expressing GFP specifi-
cally in the ICM area with NANOG, and subsequent analysis indi-
cated that GFP-expressing ESCs are NANOG negative, whereas290 Cell 148, 285–295, January 20, 2012 ª2012 Elsevier Inc.remaining host embryo ICM cells strongly
express NANOG. Thus, these results support
the notion that although cleaving host embryos
can incorporate ESCs, the environment does
not support undifferentiated growth of ESCs.
During the 4–5 day window that is required for
injected embryos to reach the blastocyst stage,
aggregated ESCs undergo differentiation and
lose pluripotency. This phenomenon is likely
to preclude contribution of ESCs to the fetal
tissues and organs.
DISCUSSION
Based on the comprehensive analysis of the
developmental potency in vivo, we demonstrate
that monkey blastocysts do not readily aggre-
gate with transplanted ICMs or ESCs and form
embryo proper chimeras (Figure 5). Our results
suggest that cells within monkey ICMs, even
in early preimplantation blastocysts, are not
homogeneous. We detected two cell typeswithin monkey ICMs where a cluster of NANOG-positive EPI
cells is covered by GATA-6-positive PE cells. Mouse studies
have shown that segregation of ICMs into EPI and PE becomes
apparent in mouse peri-implantation stage blastocysts (E4.5)
(Cockburn and Rossant, 2010). Mouse chimeras are routinely
generated using E3.5 host blastocysts, where the ICM is not
visibly differentiated into EPI and PE fates yet. However, differen-
tiation and lineage commitment in later-stage blastocysts signif-
icantly inhibit integration of injected ESCs into EPI and formation
of embryo proper chimeras (Ohta et al., 2008). It is possible that
segregation of ICMs seen in monkey blastocysts may have
diminished their ability to incorporate foreign cells and develop-
ment of embryo proper chimeras.
Remarkably, transplantedmonkey ICMs developed into viable
fetuses with a TE support from a host blastocyst. This demon-
strates an extraordinary developmental potential of primate
ICMs compared to that of established ESCs.
Mouse studies showed that in addition to the embryo proper,
the EPI gives rise to several extraembryonic derivatives including
amniotic ectoderm, extraembryonic mesoderm of the amnion,
allantois, visceral yolk sac, and chorion (Gardner, 1983; Mackay
andWest, 2005). The PE contributes to the endoderm layer of the
visceral yolk sac and the parietal endoderm associated with
Reichert’s membrane. The TE part underlying the ICM, known
Figure 4. Detection of ESCs in Blastocysts Devel-
oped from Four-Cell Embryos Injected with GFP-
Positive ESCs
(A) GFP-expressing ESCs were injected into four-cell
embryos and placed between blastomeres.
(B) Blastocysts with GFP-embedded cells.
(C–E) Immune staining for NANOG demonstrated that
GFP-expressing ESCs within an ICM were NANOG
negative, indicating premature differentiation.
Original magnifications: (A–E), 3200.as the polar trophectoderm, forms the chorionic ectoderm and
placental trophoblast, whereas the TE part surrounding the blas-
tocyst cavity, known as the mural trophectoderm, contributes to
the primary trophoblast giant cells (Mackay and West, 2005).
Thus, whereas the embryo proper develops exclusively from
the ICM, both the ICM and TE contribute to the extraembryonic
lineages. In this study, we did not incorporate easily traceable
markers that would allow examination of what specific extraem-
bryonic cells and layers were contributed by the host embryo or
developed from the transplanted ICMs. However, DNA analysis
of mixed extraembryonic samples containing presumably cho-
rion and amnion revealed that both host embryo and injected
ICMs contributed to these tissues.
Chimerism in the body of ICM twins produced in this studywas
limited to organs rich in blood, suggesting that placental vascular
anastomoses and blood mixture could be involved rather than
true chimerism in solid tissues. Blood chimerism has been re-
ported in human twin pregnancies (van Dijk et al., 1996). Interest-
ingly, in marmosets and other callitrichid primates, even fraternal
twins exchange blood through chorionic fusions, and up to 95%
of pregnancies result in the birth of hematopoietic chimeras
(Gengozian et al., 1964). Asmentioned above, naturally occurring
human monochorionic twins are predominantly monozygotic,
but rare cases of monochorionic dizygotic twin pregnancies
have been reported in association with clinical IVF procedures
(Quintero et al., 2003; Souter et al., 2003). Monochorionic preg-
nancies carry increased risk of abortions or premature birth
due to aberrant vascularizations leading to twin-to-twin transfu-
sion syndrome and/or vascular disruptions. In the case of our
monkey twin fetuses, wedid not find any apparentmalformations
or abnormalities, and examination of the placenta showed
no obvious defects. Our experimental approach for generating
offspring from transplanted ICMs may represent an important
nonhumanprimatemodel for studying thedevelopment of genet-
ically different fetuses in a monochorionic environment.
In contrast to ICMs, monkey ESCs did not form completely
stem cell-derived fetuses, most likely due to inability of hostCell 148, 28embryos to support with vital extraembryonic
tissues. Comparative studies between mouse
ICMs and ESCs suggested that the latter are
restricted to the embryo proper and extraem-
bryonic mesoderm lineages, whereas ICMs
contribute to the embryo proper and a wide
range of extraembryonic lineages (Beddington
and Robertson, 1989; Tam and Rossant, 2003).
Particularly, it is well known that mouse ESCsare not capable of contributing to the PE lineage that gives rise
to yolk sac, a critical structure for normal fetal development (Bed-
dington and Robertson, 1989; Rossant, 2007). Chimera studies
indicated that this lineage is preserved in isolated mouse ICMs,
and when transplanted into host embryo, ICMs can contribute to
the PE (Tam and Rossant, 2003). Interestingly, although mouse
ICMs injected into host diploid (2N) blastocysts form chimeras,
their ability to develop into separate fetuses has not been
reported.
Mouse ESCs can develop into whole stem cell-derived
offspring when aggregated with tetraploid (4N) host embryos
(Nagy et al., 1990, 1993). Chimera studies with 4N-2N embryos
have shown that tetraploid cells can contribute to functional tro-
phectoderm and PE lineages but not to the EPI (James et al.,
1995). Thus, in mouse ESC-4N chimeras, two embryonic cell
types complement each other, with ESCs forming the embryo
proper, and 4N embryos developing into extraembryonic line-
ages. It is important to note that tetraploid complementation is
considered to be themost stringent but extremely inefficient plu-
ripotency test for mouse ESCs. Although the majority of mouse
ESC lines do contribute to conventional chimeras, only selected
lines are able to produce whole ESC-derived live offspring after
aggregation with tetraploid host embryos (Nagy et al., 1990,
1993).
We also demonstrate here that totipotent, cleaving monkey
embryos cannot serve as a host for testing pluripotency of
ESCs. Unlike mouse, where two- to eight-cell stage embryos
engraft ESCs and form chimeras (Wood et al., 1993), cleaving
primate embryos do not seem to provide a niche for undifferen-
tiated maintenance of ESCs until the host ICM is formed.
Although we did not test directly in this study, it is likely that
ICMs injected into four-cell embryos would also prematurely
differentiate. Based on these results, it is reasonable to specu-
late that a chimera assay is not a feasible pluripotency assay
with the approaches employed here.
The ability of mouse pluripotent cells to generate chimeras or
completely ESC-derived offspring incited ethical concerns that5–295, January 20, 2012 ª2012 Elsevier Inc. 291
Figure 5. Summary of Chimera Studies with Monkey Embryos and Embryonic Cells
Rhesus monkey ESCs as well as isolated ICMs, blastomeres, or whole embryos were tested for their ability to incorporate into host embryos and generate
chimeric offspring. Established ESCs and freshly isolated ICMs failed to produce chimeras when injected into host blastocysts. However, ICMs developed into
separate fetuses with placental support from the host embryo. Aggregating of several four-cell embryos efficiently produced live chimeric offspring.
See also Figure S7 and Movie S1.human ESCs and iPSCs could be used to clone humans or
create chimeras (Lanza, 2007). However, based on our study,
these concerns seem to be unattainable or more challenging,
at least when using monkey cells and embryos.
On the other hand, although monkey ESCs did not contribute
to fetuses in our study, we cannot rule out their broad pluripo-
tency and ability to differentiate to many if not all cell types of
the embryo proper. As we previously described, monkey ESCs
can form teratomas in vivo or differentiate in vitro into a broad
range of cell and tissue types representing all three germ layers
(Mitalipov et al., 2006). It will be important to develop additional
in vivo assays defining potency of primate ESCs and determining
their potential in regenerative medicine. In addition, further
studies with other human or monkey experimental pluripotent
stem cells may be warranted.
On a related issue, monkey and human ESCs are considered
to be more similar to mouse epiblast stem cells (EpiSCs) derived
from postimplantation stage embryos than to mouse ESCs292 Cell 148, 285–295, January 20, 2012 ª2012 Elsevier Inc.(Brons et al., 2007; Rossant, 2008; Tesar et al., 2007). Notably,
although mouse EpiSCs can differentiate into teratomas, they
display limited capacity to form chimeras. Therefore, failure of
monkey ESCs to contribute to chimeras may be due to their
epiblast stem cell-like nature. Interestingly, recent studies have
shown that mouse EpiSCs can be converted to more potent
‘‘naive’’ ESC state capable of forming chimeras (Guo et al.,
2009). It has been speculated that human and monkey ESCs
can be also directed toward a similar naive state (Hanna et al.,
2010). If such cells become available, our chimera assay would
be critical for ultimate testing of their potential.
We demonstrate here that aggregating of three or more
cleaving monkey embryos results in chimeric offspring with
extensive contribution to the embryo proper and extraembryonic
lineages. In fetuses, chimerism was present in all tissues and
organs including gonads, suggesting a broad developmental
potential of parental blastomeres. Moreover, because we aggre-
gated up to six individual embryos per chimera, we observed
that both female (XX) andmale (XY) parental embryos contributed
to a chimera. Gender ratio inmouse chimeras produced by injec-
tion of male ESCs is skewed toward males due to conversion of
some sex (XY-XX) chimeras into phenotypic males (Delhaise
et al., 1993). All three live infants in our study were phenotypically
male, suggesting that presence of XY cells may also convert
chimeras to males. Based on the cytogenetic analysis of blood,
sex chimerism was confirmed in one infant. It would be critical
to investigate further chimerism in various tissues including
gonads and reproductive capacity in these animals.
Remarkable in vivo developmental rates were obtained when
several four-cell embryos were aggregated together. It would
be interesting to investigate whether such ‘‘enhanced’’ host
embryos can improve chimera outcomes with ESCs. Another
potential use of this chimera assay is to enhance or complement
development of clonedmonkey embryos.We previously demon-
strated that monkey SCNT embryos are capable of developing
efficiently into ESCs (Byrne et al., 2007; Sparman et al., 2009).
However, their in vivo potential after transfer into recipients
remains limited. We have been able to establish several early
pregnancies, but none of them progressed to term (Sparman
et al., 2010). Aggregation chimeras of SCNT embryos with fertil-
ized counterparts would be extremely useful to determine
whether developmental failure of SCNT embryos is due to ineffi-
cient reprogramming into specific extraembryonic or embryo
proper lineages.
Currently, there is little known about human and nonhuman
primate embryo development and lineage specification and
how closely the mouse development reflects primates. Our
study presents an indication of the similarities and differences
between mouse and primate preimplantation embryo develop-
ment and offers an important experimental model to investigate
lineage commitment and interactions.
EXPERIMENTAL PROCEDURES
All animal procedures were approved by the Institutional Animal Care and Use
Committee at the ONPRC/OHSU.
ESC Culture and Preparation for Injections
ESCswere culturedon a feeder layer consisting ofmouse embryonic fibroblasts
(MEFs) in DMEM/F12 medium with high glucose but without sodium pyruvate
and supplemented with 1% nonessential amino acids, 2 mM l-glutamine,
0.1 mM b-mercaptoethanol, and 15% FBS at 37C, 3% CO2, 5% O2, and
92%N2. Established rhesus monkey ESCs were fully characterized and tested
by in vitro and in vivo differentiation as previously described (Byrne et al., 2007;
Mitalipovetal., 2006).TogenerateGFP-expressingcells,ESCswere transduced
with replication-deficient lentiviral vector carrying a GFP reporter gene down-
streamof thepSin-EF2-Puromycin sequence (Addgene, Inc). Twenty-four hours
after transduction, ESCs were split onto new puromycin-resistant MEF feeders
and cultured in a mediumwith 2 mg/ml puromycin for 2–3 days. Culture medium
was changed daily, and ESC colonies were typically split every 5–7 days by
manual dissociation and replating collected clumps onto fresh MEFs.
For disaggregation prior to injections, ESCs were treated with nonenzymatic
TRYPLE (Invitrogen), dissociated by pipetting into single cells, and resus-
pended with TH3 medium. Alternatively, ESC colonies were manually picked
up and mechanically dispersed to smaller clumps before injections.
Injection of ESCs
Embryos were generated by intracytoplasmic sperm injection (ICSI) as
described in the Extended Experimental Procedures. Host embryos at thefour-cell or blastocyst stages were transferred to a 30 ml manipulation droplet
of TH3 placed on the center of glass bottom manipulation dishes (http://www.
wpiinc.com) covered with paraffin oil (Zander IVF). ESCs were placed into
a separate 5 ml droplet next to the manipulation drop containing host embryos.
A host blastocyst was held with holding pipette with an ICM positioned at 12
o’clock (see Movie S1). Approximately 20–30 disaggregated ESCs or clumps
of cells were drawn into an injection pipette. A single laser pulse (http://www.
hamiltonthorne.com) was fired to ablate the zona pellucida and underlying tro-
phectodermal layer, and an injection pipette was immediately pierced through
the hole. Next, ESCs were expelled and placed close to the host ICM (see
Movie S1). Injected blastocysts were immediately transferred into oviducts
of synchronized recipient females. For four-cell stage host embryos, ESCs
were injected between blastomeres, and embryos were cultured to the blasto-
cyst stage. When GFP-expressing ESCs were used, GFP expression was
regularly monitored with an epifluorescent microscope. Only blastocysts
with visible GFP-expressing cells were transferred into recipients.
Injection of ICMs
Intact ICMs were isolated by immunosurgery. In brief, the zona pellucida from
each blastocyst was removed by brief (10 s) treatment with 0.5% protease
(pronase, Sigma, P-8811). Blastocysts were then incubated in anti-monkey
whole serum (Sigma, M-0403) for 30 min at 37C, washed three times
with TH3, and transferred into Guinea pig complement (Sigma, S-1639) for
30 min. Blastocysts were gently pipetted with a small bore pipette to disperse
lysed trophectodermal cells, and isolated ICMs were washed and immediately
injected into host blastocysts as described above (See Movie S1).
Blastomere Replacement
Four-cell stage (D2) embryos were generated by ICSI from unrelated females
and treated with 0.5% pronase to remove zona pellucida. Embryos were incu-
bated in Ca- and Mg-free medium (Invitrogen) for 15 min and transferred to
30 ml manipulation drop of TH3 medium containing 10 mg/ml cytochalasin
B. Embryos were further incubated at 37C for an additional 10–15 min before
manipulation. Blastomeres from a four-cell embryo were split in half using an
injection pipette (45–50 outer diameter, polished), and each half (two blasto-
meres) was transferred inside of two separate empty zona pellucida. Then,
another half set of blastomeres from an unrelated female was added under
each zona. Aggregated embryos were cultured to the blastocyst stage and
transferred into oviducts of synchronized recipients.
Whole-Embryo Aggregation
Four-cell stage (D2) embryos were treated with 0.5% pronase to remove zona
pellucida. Three to six zona-free embryos were aggregated together by
mechanically pushing against each other. Aggregates were transferred into
30 ml culture drop containing HECM-9 medium and cultured individually at
37C in 6% CO2, 5% O2, and 89% N2.
Embryo Transfers
Beginning 8 days after menses during a spontaneous menstrual cycle, blood
samples were collected daily from the saphenous vein of rhesus females
for estradiol level analysis by radioimmunoassay. The day after the serum
estradiol peak was considered the day of ovulation (day 0). This peak occurred
on average on day 11 post-menses, with a range from 8 to 17 days. Two to six
days after the estradiol peak, embryos were transferred surgically into the
oviduct ipsilateral to the ovary bearing the ovulatory stigma, a described previ-
ously (Wolf et al., 2004).
Fetal Recovery and Sample Collection
Fetuses were recovered by cesarean section at midgestation, and fetuses
were euthanized with transumbilical cord injection of pentobarbital. Autopsies
were conducted to collect tissues from each organ separately.
Parentage Analysis
DNA was extracted from blood or tissues using commercial kits (Gentra). STR
microsatellite parentage analysis was conducted by the Veterinary Genetics
Laboratory at University of California, Davis as described previously (Byrne
et al., 2007; Tachibana et al., 2009). In brief, six multiplexed PCR reactionsCell 148, 285–295, January 20, 2012 ª2012 Elsevier Inc. 293
were set up for the amplification of 39 markers representing 25 autosomal loci
and 14 autosomal, MHC-linked loci. On the basis of the published rhesus
macaque linkage map (Rogers et al., 2006), these markers are distributed in
19 chromosomes. Two of the markers included in the panel, MFGT21 and
MFGT22 (Domingo-Roura et al., 1997), were developed from Macaca fuscata
and do not have chromosome assignment.
For gender determination, X- and Y-linked zinc finger protein genes (ZFX
and ZFY) were amplified as previously described (Mitalipov et al., 2007).
MtDNA analysis was performed as previously described (Tachibana et al.,
2009). In brief, the rhesus macaque mitochondrial D loop hypervariable
region 1 (RhDHV1) sequence was amplified using forward (50-CCAACACCCA
AAGCTGGCATTCTA-30) and reverse (50-ATGGCCCTGAGGTAAGAACCA
GAT-30) primers. PCR analysis was performed using PCR super mix high-
fidelity DNA polymerase (Invitrogen) containing 0.5 mM of each primer (final
volume 50 ml). Reaction conditions were initial denaturation at 94C for
5 min; 35 cycles of denaturation at 94C for 30 s; annealing at 60C for 30 s;
extension at 68C for 90 s; and a final extension at 68C for 3 min, generating
547 bp of sequence covering the RhDHV1 region. PCR products were
sequenced, and informative SNPs encompassing Macaca mulatta mtDNA
nucleotide positions 15974–16516 (GenBank NC_005943) were identified
using Sequencher v. 4.7 software (GeneCodes). For restriction fragment length
polymorphism (RFLP) analysis, PCR products were amplified as described
above. Unique restriction digestion sites were identified with Sequencher
v. 4.7. Restriction enzymes were from Fermentas. For reactions, quantity of
PCR products was adjusted to 500 ng and digested by appropriate enzymes.
Samples were analyzed using 3% agarose gel.
For PCR-baseddetection of ESCprogenycarryingGFP, eGFPsequencewas
amplified using forward (50-GCACAAGCTGGAGTACAACTACAACAGC-30) and
reverse (50-TCACGAACTCCAGCAGGACCAT-30) primers as previously de-
scribed (Sasaki et al., 2009).PCRreactionwasperformedas follows: initial dena-
turation at 94C for 5min; 35 cycles of denaturation at 94C for 30 s; annealing at
58C for 30 s; extension at 68C for 90 s; and final extension at 68C for 3 min.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, six tables, and one movie and can be found with this article online at
doi:10.1016/j.cell.2011.12.007.
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